Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation

Shin Jung Park, Prakash Thapa, Hye Jin Seo, Eun Seok Park, Seong Hoon Jeong

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'Early formulation development of CKD-519, a new CETP inhibitor, for phase 1 clinical study based on in vitro and in vivo evaluation'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science